Investment
Fortune
Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
Why This Matters
Cuban’s Cost Plus Drugs, which he founded in 2022, similarly provides direct-to-consumer discounted pharmaceuticals.
October 2, 2025
11:03 AM
4 min read
Positive
Stay Ahead of the Market
Get weekly insights into market shifts, investment opportunities, and financial analysis delivered to your inbox.
No spam, unsubscribe anytime